PortViewPortView
Hoth Therapeutics logo

Hoth Therapeutics (HOTH) Stock Analysis

NASDAQHealthcareBiotechnology

$0.80-2.22%
1-year price historyRange $0.51 – $2.22
52-week range$0.80
$0.49$2.45

What Hoth Therapeutics does

Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.

Key metrics

Market cap
$10.62M
P/E (TTM)
-1.00
EPS (TTM)
$-0.80
Beta
0.53
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$0.80
200-day avg
$1.11
52-week high
$2.45
52-week low
$0.49
CEO
Robb Knie

ETFs linked to HOTH

Broad-market and Healthcare sector ETFs an investor holding Hoth Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how HOTH fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze HOTH in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Hoth Therapeutics?
Hoth Therapeutics trades under the ticker HOTH on NASDAQ.
Which exchange is HOTH listed on?
HOTH is listed on NASDAQ.
What sector does Hoth Therapeutics operate in?
Hoth Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze HOTH in a portfolio?
PortView shows HOTH's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.